The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose-finding study of OPB-111077, a novel STAT3 inhibitor, in patients with advanced hepatocellular carcinoma.
 
Changhoon Yoo
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Ipsen
 
Jihoon Kang
No Relationships to Disclose
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Ho Yeong Lim
No Relationships to Disclose
 
Jee Hyun Kim
No Relationships to Disclose
 
Myung Ah Lee
No Relationships to Disclose
 
Tae-You Kim
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose